Drugs often used to reduce insulin resistance in obese patients with PCOS include metformin, glucagon-like peptide-1 (GLP-1) receptor agonists, and thiazolidinediones (TZDs) (7). Here, GLP1R is linked to polycystic ovary syndrome.